P Gressens Selected Research

P Gressens Research Topics

Disease

7	Hypoxia (Hypoxemia) 07/2014 - 06/2001
4	Inflammation (Inflammations) 01/2021 - 12/2008
4	Brain Injuries (Brain Injury) 07/2014 - 12/2007
3	Ischemia 09/2011 - 06/2001
3	Cerebral Palsy (Spastic Diplegia) 01/2011 - 07/2001
2	Stroke (Strokes) 09/2011 - 12/2008
2	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 10/2003 - 01/2001
2	Infections 01/2003 - 01/2000
2	Zellweger Syndrome (Zellweger's Syndrome) 09/2000 - 01/2000
1	Neurodevelopmental Disorders 10/2018
1	Hypothermia 07/2014
1	Asphyxia (Suffocation) 07/2014
1	Brain Hypoxia (Cerebral Hypoxia) 07/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2013
1	Brain Ischemia (Cerebral Ischemia) 12/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Malnutrition (Nutritional Deficiencies) 04/2008
1	Wounds and Injuries (Trauma) 12/2007
1	Learning Disabilities (Learning Disability) 12/2007
1	Hirschsprung Disease (Hirschsprung's Disease) 09/2007
1	Vipoma (WDHA) 09/2007
1	Ileus 09/2007
1	Crohn Disease (Crohn's Disease) 09/2007
1	Ulcerative Colitis 09/2007
1	Neoplasms (Cancer) 09/2007
1	Cysts 10/2003
1	Shaken Baby Syndrome 07/2002
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2001
1	Virus Diseases (Viral Diseases) 04/2001
1	Maternal Phenylketonuria 04/2001
1	Group II Malformations of Cortical Development 09/2000
1	Peroxisome biogenesis disorders 01/2000

Drug/Important Bio-Agent (IBA)

4	Neuroprotective AgentsIBA 12/2013 - 07/2001
3	Proteins (Proteins, Gene)FDA Link 01/2011 - 09/2000
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 10/2018
2	Glutamic Acid (Glutamate)FDA Link 12/2007 - 07/2002
2	N-Methylaspartate (NMDA)IBA 05/2003 - 12/2001
2	CytokinesIBA 05/2003 - 01/2000
1	LipidsIBA 10/2018
1	LipopolysaccharidesIBA 10/2018
1	Analgesics (Analgesic Drugs)IBA 07/2014
1	SympatholyticsIBA 07/2014
1	Dexmedetomidine FDA Link 07/2014
1	Noble Gases (Rare Gases)IBA 12/2013
1	CaspasesIBA 09/2011
1	quinolin- 2- carbonyl- VD(OMe)VAD(OMe)- CH2- O(2,6F2)PhIBA 09/2011
1	IronIBA 04/2008
1	MelatoninIBA 12/2007
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 09/2007
1	Insulin (Novolin)FDA Link 09/2007
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2003
1	Dizocilpine Maleate (Dizocilpine)IBA 05/2003
1	tianeptine (Stablon)IBA 05/2003
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2003
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2003
1	SulfitesIBA 12/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2001
1	Betamethasone (Celestone)FDA Link 12/2001
1	Interleukin-9 (Interleukin 9)IBA 08/2001
1	(3- tert- butyl- 8- phenylethylamino- 3,4- dihydro- 2H- 1,4- benzoxazin- 5- yl)phenylmethanoneIBA 07/2001
1	(3- cyclopentyl- 8- benzylamino- 3,4- dihydro- 2H- 1,4- benzoxazin- 5- yl)phenylmethanoneIBA 07/2001
1	Adenosine Triphosphate (ATP)IBA 07/2001
1	Messenger RNA (mRNA)IBA 07/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2001
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2001
1	Neuropilin-1IBA 06/2001
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2001
1	Ethanol (Ethyl Alcohol)IBA 04/2001
1	Cocaine (Cocaine HCl)IBA 04/2001
1	Caffeine (No Doz)FDA LinkGeneric 01/2001
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2000
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2000
1	Docosahexaenoic AcidsIBA 01/2000

Therapy/Procedure

1	Induced Hypothermia 07/2014
1	Hyperbaric Oxygenation 12/2013
1	Critical Care (Surgical Intensive Care) 12/2008
1	Caloric Restriction 04/2008
1	Therapeutics 01/2003
1	Injections 08/2001